Dose Response Assay
Dose Response Assay - Related Videos
01:03
Dose-Response Relationship: Overview
0 Views •
2023
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
01:22
Dose-Response Relationship: Potency and Efficacy
0 Views •
2023
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:25
Dose-Response Relationship: Selectivity and Specificity
0 Views •
2023
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:21
Dose Response Curve: Conventional Versus Nonmonotonic
0 Views •
2026
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
05:22
A Multiplex Serological Assay for the Detection of Antibody Responses to Arboviruses
0 Views •
2025
Multiplex fluorescence immunoassays are becoming a reference for serology testing. Their application, however, is limited by the complexity and time-consuming bead-analyte coupling processes. This report presents a semi-automated, reproducible multiplex microsphere bead coupling protocol that is comparable to the standard method while considerably reducing time to results.
FAQs
A dose-response curve links measured biological effects to the concentrations that produced them. Examining the complete pattern shows whether activity changes across the tested range and supplies a quantitative basis for comparing agents. In immunology and infection studies, this can distinguish how strongly different drugs, antibodies, cytokines, or pathogen-derived molecules affect the same biological system.
An EC50 estimate identifies the concentration associated with a half-maximal effect, whereas an IC50 estimate identifies the concentration associated with half-maximal inhibition. These values condense a concentration-response relationship into comparable quantitative measures. Depending on whether the experiment evaluates activation or suppression, selecting the appropriate value helps describe the agent’s activity in the tested biological system.
Responses at only one concentration cannot show how a biological effect changes as the dose increases. A concentration series reveals the pattern needed to construct a curve and estimate half-maximal values. This range is especially relevant when assessing antimicrobial activity, neutralization, immune-cell activation, toxicity, or treatment efficacy, because each outcome can be evaluated across multiple levels of the test agent.
The workflow begins by preparing serial dilutions of the selected test agent, such as a drug, antibody, cytokine, or pathogen-derived molecule. Each concentration is applied to a biological system, and the resulting effects are measured across the series. The measurements are then organized by concentration to generate a dose-response curve and estimate relevant half-maximal values.
In these fields, researchers can use the approach to examine antimicrobial activity, determine how effectively an agent neutralizes a target, measure immune-cell activation, assess toxicity, or evaluate treatment efficacy. The biological system and measured response change with the research question, while the concentration series provides a common framework for quantifying the agent’s effect.
It can show how the measured biological response changes as antibody or cytokine concentration increases, allowing investigators to quantify activity within the tested system. The resulting curve supports comparisons among test agents and can provide an effective-concentration estimate. In infection-related work, the same strategy can help examine neutralization or other responses linked to the biological effect under study.